What is the treatment for persistent Mal de Debarquement Syndrome?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 21, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Persistent Mal de Debarquement Syndrome

For persistent MdDS, the most effective treatment is vestibular rehabilitation using the "roll readaptation" technique, which involves rolling the head rhythmically while viewing full-field optokinetic stimulation for 4-5 days, achieving significant improvement in 78% of classic MdDS cases and complete remission in 27%. 1

Primary Treatment Approach: Roll Readaptation Protocol

The roll readaptation technique represents the first successful evidence-based treatment for MdDS and should be initiated as soon as the diagnosis is confirmed 1. This approach directly targets the maladaptive vestibular-ocular reflex that underlies the persistent rocking sensations 2.

Treatment Protocol Details

  • Duration: 4-5 consecutive days of treatment sessions 1
  • Technique: Patient's head is rolled rhythmically while watching a rotating full-field visual surround (optokinetic stimulus) 1
  • Session length: Up to 4 minutes at a time per rolling sequence 2
  • Assessment parameters: Measure the patient's specific rocking frequency, body drifting patterns, and presence of nystagmus before treatment to individualize the visual stimulus parameters 1

Expected Outcomes

  • Initial response: 78% of classic MdDS patients achieve >50% symptom reduction after the initial treatment week 1
  • Long-term maintenance: 52% of classic MdDS patients maintain significant improvement at 1-year follow-up 1
  • Complete remission: 27% of classic MdDS patients achieve complete symptom resolution 1
  • Rapid functional recovery: Patients can return to full-time work within weeks, even after months of disability 2

Critical Timing Considerations

Early treatment is essential—treatment success is inversely correlated with both symptom duration and patient age 1. The longer MdDS persists beyond 6 months, the lower the likelihood of remission with any intervention 3, 4. Therefore, aggressive early treatment within the first 6 months maximizes the probability of sustained improvement.

Alternative Treatment: Vestibular Migraine Protocol

When roll readaptation is unavailable or for patients with concurrent migraine history, manage as vestibular migraine 3:

Pharmacotherapy Options

  • Verapamil (calcium channel blocker)
  • Nortriptyline (tricyclic antidepressant)
  • Topiramate (anticonvulsant)
  • Combination therapy of the above agents 3

Lifestyle Modifications

Implement migraine-specific lifestyle changes including sleep hygiene, dietary triggers avoidance, and stress management 3.

Evidence for This Approach

This protocol achieved 73% response rate in MdDS patients, significantly better than the control group treated with standard vestibular rehabilitation alone 3. Nearly all MdDS patients have personal or family history of migraine or atypical migraine symptoms, supporting this pathophysiologic link 3.

Experimental Treatment: Repetitive Transcranial Magnetic Stimulation (rTMS)

For refractory cases unresponsive to roll readaptation or migraine protocols, consider rTMS 4:

Protocol Specifications

  • Target: Dorsolateral prefrontal cortex (DLPFC)
  • Frequency: 10 Hz (high frequency) stimulation
  • Laterality: Right-handed patients respond best to left DLPFC stimulation; left-handed patients respond best to right DLPFC stimulation 4
  • Avoid: Low-frequency (1 Hz) stimulation, which can worsen symptoms 4

Limitations

This remains investigational with only short-term pilot data available 4. Duration of symptoms negatively correlates with treatment response 4.

Common Pitfalls to Avoid

Post-Treatment Travel Precautions

Prolonged travel by air or car immediately after successful treatment frequently causes symptomatic reversion 1. Patients should minimize passive motion exposure for at least 2-4 weeks following treatment completion to prevent relapse.

Ineffective Approaches

  • Standard vestibular rehabilitation/physical therapy alone: Demonstrates lower improvement rates compared to roll readaptation or migraine protocols 3
  • Purely palliative medical management: All traditional medical treatments are only palliative without addressing the underlying pathophysiology 4
  • Delayed treatment: Symptoms persisting beyond 6 months show progressively lower likelihood of remission 3, 4

Spontaneous-Onset MdDS

For spontaneous MdDS (not triggered by travel), treatment outcomes are less favorable 1:

  • Initial significant improvement: 48% (versus 78% for classic MdDS)
  • Maintained improvement at 1 year: 48%
  • Complete remission: 19% (versus 27% for classic MdDS) 1

The same roll readaptation protocol should still be attempted, but patients should be counseled about the lower expected response rates 1.

Objective Monitoring

Use static posturography before and after the treatment week to objectively document improvement, though subjective 10-point symptom severity scales correlate well with functional outcomes 1.

References

Research

Treatment of Mal de Debarquement Syndrome in an Audiology-Vestibular Clinic.

Journal of the American Academy of Audiology, 2022

Research

Repetitive transcranial magnetic stimulation for mal de debarquement syndrome.

Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology, 2013

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.